Global Infectious Disease In-vitro Diagnostic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 30-Nov-2021
No. of pages: 95

The Infectious Disease In-vitro Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infectious Disease In-vitro Diagnostic size is estimated to be USD 67 million in 2026 from USD 58 million in 2020, with a change % between 2020 and 2021. The global Infectious Disease In-vitro Diagnostic market size is expected to grow at a CAGR of 3.7% for the next five years.

Market segmentation

Infectious Disease In-vitro Diagnostic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Immunoassay

- Molecular Diagnostics

- Microbiology

- Others

Market segment by Application, can be divided into

- COVID-19

- MRSA

- Clostridium Difficile

- Respiratory Virus

- TB and Drug-resistant TB

- Chlamydia

- Gonorrhea

- HPV

- HIV

- Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

Market segment by players, this report covers

- BD

- BioMérieux SA

- Abbott

- Quidel Corporation

- OraSure Technologies, Inc.

- Hologic, Inc. (Gen Probe)

- Danaher

- QIAGEN

- Roche

- Siemens Healthineers AG

- Bio-Rad Laboratories, Inc.

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Infectious Disease In-vitro Diagnostic product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Infectious Disease In-vitro Diagnostic, with revenue, gross margin and global market share of Infectious Disease In-vitro Diagnostic from 2019 to 2021.

Chapter 3, the Infectious Disease In-vitro Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Infectious Disease In-vitro Diagnostic market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Infectious Disease In-vitro Diagnostic research findings and conclusion, appendix and data source.

Global Infectious Disease In-vitro Diagnostic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Infectious Disease In-vitro Diagnostic
1.2 Classification of Infectious Disease In-vitro Diagnostic by Type
1.2.1 Overview: Global Infectious Disease In-vitro Diagnostic Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type in 2020
1.2.3 Immunoassay
1.2.4 Molecular Diagnostics
1.2.5 Microbiology
1.2.6 Others
1.3 Global Infectious Disease In-vitro Diagnostic Market by Application
1.3.1 Overview: Global Infectious Disease In-vitro Diagnostic Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 COVID-19
1.3.3 MRSA
1.3.4 Clostridium Difficile
1.3.5 Respiratory Virus
1.3.6 TB and Drug-resistant TB
1.3.7 Chlamydia
1.3.8 Gonorrhea
1.3.9 HPV
1.3.10 HIV
1.3.11 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
1.4 Global Infectious Disease In-vitro Diagnostic Market Size & Forecast
1.5 Global Infectious Disease In-vitro Diagnostic Market Size and Forecast by Region
1.5.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region, (2016-2021)
1.5.3 North America Infectious Disease In-vitro Diagnostic Market Size and Prospect (2016-2026)
1.5.4 Europe Infectious Disease In-vitro Diagnostic Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size and Prospect (2016-2026)
1.5.6 South America Infectious Disease In-vitro Diagnostic Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infectious Disease In-vitro Diagnostic Market Drivers
1.6.2 Infectious Disease In-vitro Diagnostic Market Restraints
1.6.3 Infectious Disease In-vitro Diagnostic Trends Analysis
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Infectious Disease In-vitro Diagnostic Product and Solutions
2.1.4 BD Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 BD Recent Developments and Future Plans
2.2 BioMérieux SA
2.2.1 BioMérieux SA Details
2.2.2 BioMérieux SA Major Business
2.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Product and Solutions
2.2.4 BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioMérieux SA Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Infectious Disease In-vitro Diagnostic Product and Solutions
2.3.4 Abbott Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Quidel Corporation
2.4.1 Quidel Corporation Details
2.4.2 Quidel Corporation Major Business
2.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Product and Solutions
2.4.4 Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Quidel Corporation Recent Developments and Future Plans
2.5 OraSure Technologies, Inc.
2.5.1 OraSure Technologies, Inc. Details
2.5.2 OraSure Technologies, Inc. Major Business
2.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product and Solutions
2.5.4 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 OraSure Technologies, Inc. Recent Developments and Future Plans
2.6 Hologic, Inc. (Gen Probe)
2.6.1 Hologic, Inc. (Gen Probe) Details
2.6.2 Hologic, Inc. (Gen Probe) Major Business
2.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product and Solutions
2.6.4 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Hologic, Inc. (Gen Probe) Recent Developments and Future Plans
2.7 Danaher
2.7.1 Danaher Details
2.7.2 Danaher Major Business
2.7.3 Danaher Infectious Disease In-vitro Diagnostic Product and Solutions
2.7.4 Danaher Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Danaher Recent Developments and Future Plans
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Product and Solutions
2.8.4 QIAGEN Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 QIAGEN Recent Developments and Future Plans
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Infectious Disease In-vitro Diagnostic Product and Solutions
2.9.4 Roche Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Roche Recent Developments and Future Plans
2.10 Siemens Healthineers AG
2.10.1 Siemens Healthineers AG Details
2.10.2 Siemens Healthineers AG Major Business
2.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product and Solutions
2.10.4 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Siemens Healthineers AG Recent Developments and Future Plans
2.11 Bio-Rad Laboratories, Inc.
2.11.1 Bio-Rad Laboratories, Inc. Details
2.11.2 Bio-Rad Laboratories, Inc. Major Business
2.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product and Solutions
2.11.4 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infectious Disease In-vitro Diagnostic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Infectious Disease In-vitro Diagnostic Players Market Share
3.2.2 Top 10 Infectious Disease In-vitro Diagnostic Players Market Share
3.2.3 Market Competition Trend
3.3 Infectious Disease In-vitro Diagnostic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infectious Disease In-vitro Diagnostic Revenue and Market Share by Type (2016-2021)
4.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2016-2021)
5.2 Infectious Disease In-vitro Diagnostic Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2026)
6.2 North America Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2026)
6.3 North America Infectious Disease In-vitro Diagnostic Market Size by Country
6.3.1 North America Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2026)
6.3.2 United States Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
6.3.3 Canada Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
6.3.4 Mexico Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2026)
7.2 Europe Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2026)
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Country
7.3.1 Europe Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2026)
7.3.2 Germany Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
7.3.3 France Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
7.3.5 Russia Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
7.3.6 Italy Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2026)
8.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2026)
8.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region
8.3.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Region (2016-2026)
8.3.2 China Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8.3.3 Japan Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8.3.4 South Korea Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8.3.5 India Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
8.3.7 Australia Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2026)
9.2 South America Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2026)
9.3 South America Infectious Disease In-vitro Diagnostic Market Size by Country
9.3.1 South America Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2026)
9.3.2 Brazil Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
9.3.3 Argentina Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2026)
10.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2026)
10.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country
10.3.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2026)
10.3.2 Turkey Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
10.3.4 UAE Infectious Disease In-vitro Diagnostic Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Infectious Disease In-vitro Diagnostic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Infectious Disease In-vitro Diagnostic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Infectious Disease In-vitro Diagnostic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Infectious Disease In-vitro Diagnostic Revenue (USD Million) by Region (2016-2021)
Table 5. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2021-2026)
Table 6. BD Corporate Information, Head Office, and Major Competitors
Table 7. BD Major Business
Table 8. BD Infectious Disease In-vitro Diagnostic Product and Solutions
Table 9. BD Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioMérieux SA Corporate Information, Head Office, and Major Competitors
Table 11. BioMérieux SA Major Business
Table 12. BioMérieux SA Infectious Disease In-vitro Diagnostic Product and Solutions
Table 13. BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott Infectious Disease In-vitro Diagnostic Product and Solutions
Table 17. Abbott Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Quidel Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Quidel Corporation Major Business
Table 20. Quidel Corporation Infectious Disease In-vitro Diagnostic Product and Solutions
Table 21. Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. OraSure Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. OraSure Technologies, Inc. Major Business
Table 24. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product and Solutions
Table 25. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Hologic, Inc. (Gen Probe) Corporate Information, Head Office, and Major Competitors
Table 27. Hologic, Inc. (Gen Probe) Major Business
Table 28. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product and Solutions
Table 29. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Danaher Corporate Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher Infectious Disease In-vitro Diagnostic Product and Solutions
Table 33. Danaher Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 35. QIAGEN Major Business
Table 36. QIAGEN Infectious Disease In-vitro Diagnostic Product and Solutions
Table 37. QIAGEN Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Roche Corporate Information, Head Office, and Major Competitors
Table 39. Roche Major Business
Table 40. Roche Infectious Disease In-vitro Diagnostic Product and Solutions
Table 41. Roche Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Siemens Healthineers AG Corporate Information, Head Office, and Major Competitors
Table 43. Siemens Healthineers AG Major Business
Table 44. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product and Solutions
Table 45. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Bio-Rad Laboratories, Inc. Major Business
Table 48. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product and Solutions
Table 49. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Infectious Disease In-vitro Diagnostic Revenue (USD Million) by Players (2019-2021)
Table 51. Global Infectious Disease In-vitro Diagnostic Revenue Share by Players (2019-2021)
Table 52. Breakdown of Infectious Disease In-vitro Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Infectious Disease In-vitro Diagnostic Players Head Office, Products and Services Provided
Table 54. Infectious Disease In-vitro Diagnostic Mergers & Acquisitions in the Past Five Years
Table 55. Infectious Disease In-vitro Diagnostic New Entrants and Expansion Plans
Table 56. Global Infectious Disease In-vitro Diagnostic Revenue (USD Million) by Type (2016-2021)
Table 57. Global Infectious Disease In-vitro Diagnostic Revenue Share by Type (2016-2021)
Table 58. Global Infectious Disease In-vitro Diagnostic Revenue Forecast by Type (2021-2026)
Table 59. Global Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021)
Table 60. Global Infectious Disease In-vitro Diagnostic Revenue Forecast by Application (2021-2026)
Table 61. North America Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Infectious Disease In-vitro Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Infectious Disease In-vitro Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Infectious Disease In-vitro Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Infectious Disease In-vitro Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Infectious Disease In-vitro Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Infectious Disease In-vitro Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Infectious Disease In-vitro Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Infectious Disease In-vitro Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Infectious Disease In-vitro Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Infectious Disease In-vitro Diagnostic Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Infectious Disease In-vitro Diagnostic Picture
Figure 2. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type in 2020
Figure 3. Immunoassay
Figure 4. Molecular Diagnostics
Figure 5. Microbiology
Figure 6. Others
Figure 7. Infectious Disease In-vitro Diagnostic Revenue Market Share by Application in 2020
Figure 8. COVID-19 Picture
Figure 9. MRSA Picture
Figure 10. Clostridium Difficile Picture
Figure 11. Respiratory Virus Picture
Figure 12. TB and Drug-resistant TB Picture
Figure 13. Chlamydia Picture
Figure 14. Gonorrhea Picture
Figure 15. HPV Picture
Figure 16. HIV Picture
Figure 17. Global Infectious Disease In-vitro Diagnostic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 18. Global Infectious Disease In-vitro Diagnostic Revenue and Forecast (2016-2026) & (USD Million)
Figure 19. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2016-2026)
Figure 20. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region in 2020
Figure 21. North America Infectious Disease In-vitro Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Europe Infectious Disease In-vitro Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. South America Infectious Disease In-vitro Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Middle East and Africa Infectious Disease In-vitro Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Infectious Disease In-vitro Diagnostic Market Drivers
Figure 27. Infectious Disease In-vitro Diagnostic Market Restraints
Figure 28. Infectious Disease In-vitro Diagnostic Market Trends
Figure 29. BD Recent Developments and Future Plans
Figure 30. BioMérieux SA Recent Developments and Future Plans
Figure 31. Abbott Recent Developments and Future Plans
Figure 32. Quidel Corporation Recent Developments and Future Plans
Figure 33. OraSure Technologies, Inc. Recent Developments and Future Plans
Figure 34. Hologic, Inc. (Gen Probe) Recent Developments and Future Plans
Figure 35. Danaher Recent Developments and Future Plans
Figure 36. QIAGEN Recent Developments and Future Plans
Figure 37. Roche Recent Developments and Future Plans
Figure 38. Siemens Healthineers AG Recent Developments and Future Plans
Figure 39. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 40. Global Infectious Disease In-vitro Diagnostic Revenue Share by Players in 2020
Figure 41. Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Infectious Disease In-vitro Diagnostic Revenue Market Share in 2020
Figure 43. Global Top 10 Players Infectious Disease In-vitro Diagnostic Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Infectious Disease In-vitro Diagnostic Revenue Share by Type in 2020
Figure 46. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Type (2021-2026)
Figure 47. Global Infectious Disease In-vitro Diagnostic Revenue Share by Application in 2020
Figure 48. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Application (2021-2026)
Figure 49. North America Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2016-2026)
Figure 50. North America Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2016-2026)
Figure 51. North America Infectious Disease In-vitro Diagnostic Revenue Market Share by Country (2016-2026)
Figure 52. United States Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2016-2026)
Figure 56. Europe Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2016-2026)
Figure 57. Europe Infectious Disease In-vitro Diagnostic Revenue Market Share by Country (2016-2026)
Figure 58. Germany Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2016-2026)
Figure 66. China Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2016-2026)
Figure 73. South America Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2016-2026)
Figure 74. South America Infectious Disease In-vitro Diagnostic Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Infectious Disease In-vitro Diagnostic Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Infectious Disease In-vitro Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
  • Global Life Sciences Microscopy Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 106
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Life Sciences Microscopy Devices manufacturers, distributors, end users, industry associations, governments' industry burea......
  • Global White Biotechnology and Enzymes Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 105
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the White Biotechnology and Enzymes companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, in......
  • Global Muscle Spasm Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 95
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Muscle Spasm Therapy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry expe......
  • Global Aneurysm Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 103
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Aneurysm Therapy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts,......
  • Global B Streptococcus (GBS) Infection Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 97
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the B Streptococcus (GBS) Infection Treatment companies, distributors, end users, industry associations, governments' industry bureaus, industry public......
  • Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 114
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, distributors, end users, industry associations, governments' industry bureaus, ......
  • Global Companion Animal Ear Infection Treatments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 99
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Companion Animal Ear Infection Treatments companies, distributors, end users, industry associations, governments' industry bureaus, industry public......
  • Global Myotonic Muscular Dystrophy (DMD) Treatments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 109
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Myotonic Muscular Dystrophy (DMD) Treatments companies, distributors, end users, industry associations, governments' industry bureaus, industry pub......
  • Global Single Use Centrifuge Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 81
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Single Use Centrifuge Systems manufacturers, distributors, end users, industry associations, governments' industry bureaus,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs